Dr. Schulte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
# Roc
Indianapolis, IN 46202Phone+1 317-944-2143Fax+1 317-944-3107
Summary
- I am a pediatric hematologist/oncologist with additional training in clinical research and pharmacology from a T32 fellowship in clinical pharmacology and MSCI degree, both at Vandebilt. My areas of clinical expertise are pediatric hematologic malignancies and vascular anomalies. I am the Medical Director of the Vascular Anomalies program at Riley Children's Health in Indianapolis and also an active member of the leukemia/lymphoma team at Riley.
Education & Training
- Vanderbilt University Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2019
- Vanderbilt University Medical CenterResidency, Pediatrics, 2012 - 2015
- Vanderbilt University School of MedicineClass of 2012
Certifications & Licensure
- IN State Medical License 2019 - 2025
- TN State Medical License 2015 - 2019
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- ZMIZ1::ABL1 Fusion: An Uncommon Molecular Event With Clinical Implications in Pediatric Cancer.Kevin T A Booth, Rachael R Schulte, Laurin Smith, Hongyu Gao, Ryan A Stohler
Archives of Pathology & Laboratory Medicine. 2025-02-01 - 1 citationsUtilization of supportive care medications and opportunities for pre-emptive pharmacogenomic testing in pediatric and young adults with leukemia.Colleen M Sakon, Carmina Sales, Selsbiel Mertami, Andra Raibulet, Rachael R Schulte
Pediatric Hematology and Oncology. 2024-10-01 - 6 citationsTreatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel
Pediatric Blood & Cancer. 2024-03-01
Journal Articles
- Effect of SLCO1B1 Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults with Leukemia and Lymphoblastic LymphomaSchulte RR, Choi L, Utreja N, Van Driest SL, Stein CM, Ho RH, Clinical and Translational Science, 2020
Press Mentions
- PRESS RELEASE: Alex’s Lemonade Stand Foundation Announces Young Investigator Grant Recipients, Cultivating Early Career Scientists in the Pediatric Oncology FieldJuly 31st, 2018
Professional Memberships
- American Society of Pediatric Hematology/OncologyMember
- Children's Oncology GroupMember
- Member
- International Society for the Study of Vascular AnomaliesMember
- ASPHO Vascular Anomalies Special Interest GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: